Can we assess the risk of embolic complications of cardioversion?

Pol Arch Med Wewn. 2016;126(1-2):5-6. doi: 10.20452/pamw.3251.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anticoagulants / therapeutic use
  • Atrial Fibrillation
  • Electric Countershock*
  • Embolism*
  • Humans
  • Thromboembolism / drug therapy

Substances

  • Anticoagulants